These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30613765)

  • 1. IDH3α regulates one-carbon metabolism in glioblastoma.
    May JL; Kouri FM; Hurley LA; Liu J; Tommasini-Ghelfi S; Ji Y; Gao P; Calvert AE; Lee A; Chandel NS; Davuluri RV; Horbinski CM; Locasale JW; Stegh AH
    Sci Adv; 2019 Jan; 5(1):eaat0456. PubMed ID: 30613765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An R132H mutation in isocitrate dehydrogenase 1 enhances p21 expression and inhibits phosphorylation of retinoblastoma protein in glioma cells.
    Miyata S; Urabe M; Gomi A; Nagai M; Yamaguchi T; Tsukahara T; Mizukami H; Kume A; Ozawa K; Watanabe E
    Neurol Med Chir (Tokyo); 2013; 53(10):645-54. PubMed ID: 24077277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased RLIP76 expression in IDH1 wild‑type glioblastoma multiforme is associated with worse prognosis.
    Wang Q; Zhang L; Cui Y; Zhang C; Chen H; Gu J; Qian J; Luo C
    Oncol Rep; 2020 Jan; 43(1):188-200. PubMed ID: 31746408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant IDH3α expression promotes malignant tumor growth by inducing HIF-1-mediated metabolic reprogramming and angiogenesis.
    Zeng L; Morinibu A; Kobayashi M; Zhu Y; Wang X; Goto Y; Yeom CJ; Zhao T; Hirota K; Shinomiya K; Itasaka S; Yoshimura M; Guo G; Hammond EM; Hiraoka M; Harada H
    Oncogene; 2015 Sep; 34(36):4758-66. PubMed ID: 25531325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
    Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G
    Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamate and α-ketoglutarate: key players in glioma metabolism.
    Maus A; Peters GJ
    Amino Acids; 2017 Jan; 49(1):21-32. PubMed ID: 27752843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic reprogramming of cancer-associated fibroblasts by IDH3α downregulation.
    Zhang D; Wang Y; Shi Z; Liu J; Sun P; Hou X; Zhang J; Zhao S; Zhou BP; Mi J
    Cell Rep; 2015 Mar; 10(8):1335-48. PubMed ID: 25732824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma.
    Krell D; Assoku M; Galloway M; Mulholland P; Tomlinson I; Bardella C
    PLoS One; 2011; 6(5):e19868. PubMed ID: 21625441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-targeting nano therapy altering IDH2-mediated EZH2/EZH1 interaction as precise epigenetic regulation in glioblastoma.
    Kaundal B; Karmakar S; Roy Choudhury S
    Biomater Sci; 2022 Sep; 10(18):5301-5317. PubMed ID: 35917200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma.
    Liu Q; Liu Y; Li W; Wang X; Sawaya R; Lang FF; Yung WK; Chen K; Fuller GN; Zhang W
    Acta Neuropathol; 2015 Oct; 130(4):587-97. PubMed ID: 26323991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic dysregulation of tricarboxylic acid cycle and oxidative phosphorylation in glioblastoma.
    Trejo-Solís C; Serrano-García N; Castillo-Rodríguez RA; Robledo-Cadena DX; Jimenez-Farfan D; Marín-Hernández Á; Silva-Adaya D; Rodríguez-Pérez CE; Gallardo-Pérez JC
    Rev Neurosci; 2024 Oct; 35(7):813-838. PubMed ID: 38841811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer.
    Gonthier K; Weidmann C; Berthiaume L; Jobin C; Lacouture A; Lafront C; Harvey M; Neveu B; Loehr J; Bergeron A; Fradet Y; Lacombe L; Riopel J; Latulippe É; Atallah C; Shum M; Lambert JP; Pouliot F; Pelletier M; Audet-Walsh É
    Mol Oncol; 2023 Oct; 17(10):2109-2125. PubMed ID: 37086156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexosaminidase B-driven cancer cell-macrophage co-dependency promotes glycolysis addiction and tumorigenesis in glioblastoma.
    Zhu C; Chen X; Liu TQ; Cheng L; Cheng W; Cheng P; Wu AH
    Nat Commun; 2024 Oct; 15(1):8506. PubMed ID: 39353936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation.
    Calvert AE; Chalastanis A; Wu Y; Hurley LA; Kouri FM; Bi Y; Kachman M; May JL; Bartom E; Hua Y; Mishra RK; Schiltz GE; Dubrovskyi O; Mazar AP; Peter ME; Zheng H; James CD; Burant CF; Chandel NS; Davuluri RV; Horbinski C; Stegh AH
    Cell Rep; 2017 May; 19(9):1858-1873. PubMed ID: 28564604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma.
    Doll S; Urisman A; Oses-Prieto JA; Arnott D; Burlingame AL
    Mol Cell Proteomics; 2017 Jan; 16(1):39-56. PubMed ID: 27834733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide methylation profiling identifies an essential role of reactive oxygen species in pediatric glioblastoma multiforme and validates a methylome specific for H3 histone family 3A with absence of G-CIMP/isocitrate dehydrogenase 1 mutation.
    Jha P; Pia Patric IR; Shukla S; Pathak P; Pal J; Sharma V; Thinagararanjan S; Santosh V; Suri V; Sharma MC; Arivazhagan A; Suri A; Gupta D; Somasundaram K; Sarkar C
    Neuro Oncol; 2014 Dec; 16(12):1607-17. PubMed ID: 24997139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation dependent down-regulation of G0S2 leads to suppression of invasion and improved prognosis of IDH1-mutant glioma.
    Fukunaga T; Fujita Y; Kishima H; Yamashita T
    PLoS One; 2018; 13(11):e0206552. PubMed ID: 30388142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of NAD(+)-dependent isocitrate dehydrogenase 3 subunit α in AFB1 induced liver lesion.
    Yang C; Fan J; Zhuang Z; Fang Y; Zhang Y; Wang S
    Toxicol Lett; 2014 Jan; 224(3):371-9. PubMed ID: 24211421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP promotes autophagy and progression of gliomas via upregulating HMGB1.
    Zhao M; Zhang Y; Jiang Y; Wang K; Wang X; Zhou D; Wang Y; Yu R; Zhou X
    J Exp Clin Cancer Res; 2021 Mar; 40(1):99. PubMed ID: 33726796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.